Nextremity Solutions’ Arcus Staple System receives FDA approval: 4 quick facts

Nextremity Solutions received FDA 510(k) approval to market its upcoming Arcus Staple System.

Advertisement

Here are four quick facts:

 

1. The staple system is indicated for fixation of bone fractures, bone reconstruction, ligament, soft tissue and tendon.

 

2. According to Ryan Schlotterback, director of product development, testing has shown that the Arcus system better maintains compression over time when compared to the competition.  

 

3. Nextremity Solutions’ application for a CE mark is pending.

 

4. Nextremity Solutions is a privately held medical device company focusing on solutions for foot and ankle surgical intervention.

 

More articles on devices:
7 key notes on Medtronic’s Q1: CEO Omar Ishrak’s take
Electrostimulation implant to help idiopathic scoliosis: 6 things to know
4 recent spine, orthopedic device company mergers & acquisitions

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.